A Study of ZT002 Injection in Participants With Overweight or Obesity
Clinical trial NCT06371326 · COMPLETED
Trial details
- NCT number
- NCT06371326
- Sponsor
- Beijing QL Biopharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2024-04-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.